Literature DB >> 24649005

Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients.

Luis Fernando Méndez-López1, Martha Imelda Dávila-Rodríguez2, Angel Zavala-Pompa3, Ernesto Torres-López4, Blanca Edelia González-Martínez5, Manuel López-Cabanillas-Lomelí5.   

Abstract

The adipokine leptin plays a critical role in the regulation of reproductive function and there has been growing interest in its potential role in the development of cancers in which obesity is an established risk factor. Serum leptin levels were found to be higher in patients diagnosed with endometrial and ovarian cancer compared to those observed in healthy individuals. This study was conducted to determine the expression of the leptin receptor (Ob-R) in endometrial biopsies of patients diagnosed with endometrial and ovarian cancer. In this preliminary study, immunohistochemistry (IHC) and the color deconvolution method were used to assess the expression levels of the Ob-R protein in three groups of endometrial tissue: one from patients diagnosed with endometrioid endometrial carcinoma, one from patients diagnosed with ovarian cancer and one from individuals without any diagnosed gynecologic disease (control group). Our results demonstrated that the highest expression of Ob-R protein in endometrial biopsies was detected in the ovarian cancer group (P=0.000). This finding suggests that changes in Ob-R expression may be assessed through the measurement of the optical density of endometrial biopsies and may become a useful tool in preventive screening, particularly for ovarian cancer.

Entities:  

Keywords:  endometrial cancer; endometrium; immunohistochemistry; leptin receptor; ovarian cancer

Year:  2013        PMID: 24649005      PMCID: PMC3917426          DOI: 10.3892/br.2013.125

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  33 in total

1.  Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new system.

Authors:  S S Cross
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

2.  Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.

Authors:  H A Lehr; T W Jacobs; H Yaziji; S J Schnitt; A M Gown
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

3.  Color deconvolution for the analysis of tissue microarrays.

Authors:  Toby C Cornish; Marc K Halushka
Journal:  Anal Quant Cytol Histol       Date:  2009-10       Impact factor: 0.302

4.  Effects of leptin on basal and FSH stimulated steroidogenesis in human granulosa luteal cells.

Authors:  S Greisen; T Ledet; N Møller; J O Jørgensen; J S Christiansen; K Petersen; P Ovesen
Journal:  Acta Obstet Gynecol Scand       Date:  2000-11       Impact factor: 3.636

5.  Association of obesity and ovarian cancer in a case-control study.

Authors:  D C Farrow; N S Weiss; J L Lyon; J R Daling
Journal:  Am J Epidemiol       Date:  1989-06       Impact factor: 4.897

6.  Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.

Authors:  Mariusz Koda; Mariola Sulkowska; Andrzej Wincewicz; Luiza Kanczuga-Koda; Boguslaw Musiatowicz; Magdalena Szymanska; Stanislaw Sulkowski
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

7.  Divergent signaling capacities of the long and short isoforms of the leptin receptor.

Authors:  C Bjørbaek; S Uotani; B da Silva; J S Flier
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

8.  Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration.

Authors:  Kerstin Lang; Janina Ratke
Journal:  Cell Commun Signal       Date:  2009-12-23       Impact factor: 5.712

9.  Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.

Authors:  Shahab Uddin; Rong Bu; Maqbool Ahmed; Jehad Abubaker; Fouad Al-Dayel; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Mol Cancer       Date:  2009-09-18       Impact factor: 27.401

10.  Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas.

Authors:  Andrzej Wincewicz; Mariusz Koda; Mariola Sulkowska; Luiza Kanczuga-Koda; Stanislaw Sulkowski
Journal:  Tissue Cell       Date:  2008-06-25       Impact factor: 2.466

View more
  5 in total

Review 1.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

2.  Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma.

Authors:  Urszula Sulkowska; Andrzej Wincewicz Febp; Stanislaw Sulkowski
Journal:  Oncol Lett       Date:  2016-05-09       Impact factor: 2.967

3.  Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors.

Authors:  Luis Fernando Méndez-López; Angel Zavala-Pompa; Elva I Cortés-Gutiérrez; Ricardo M Cerda-Flores; Martha I Davila-Rodriguez
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

Review 4.  Gynaecological cancers and leptin: A focus on the endometrium and ovary.

Authors:  A Ray; J Fornsaglio; S Dogan; S Hedau; D Naik; A De
Journal:  Facts Views Vis Obgyn       Date:  2018-03

5.  Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.

Authors:  Sumie Kato; Lorena Abarzua-Catalan; César Trigo; Ana Delpiano; Cristobal Sanhueza; Karen García; Carolina Ibañez; Katherine Hormazábal; Daniela Diaz; Jorge Brañes; Enrique Castellón; Erasmo Bravo; Gareth Owen; Mauricio A Cuello
Journal:  Oncotarget       Date:  2015-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.